Academic literature on the topic 'HIV/Hepatitis C'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'HIV/Hepatitis C.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "HIV/Hepatitis C"

1

Crobu, Maria Grazia, Paolo Ravanini, Clotilde Impaloni, et al. "Hepatitis C Virus as a Possible Helper Virus in Human Hepatitis Delta Virus Infection." Viruses 16, no. 6 (2024): 992. http://dx.doi.org/10.3390/v16060992.

Full text
Abstract:
Previous studies reported that the hepatitis C virus (HCV) could help disseminate the hepatitis D virus (HDV) in vivo through the unrelated hepatitis B virus (HBV), but with essentially inconclusive results. To try to shed light on this still-debated topic, 146 anti-HCV-positive subjects (of whom 91 HCV/HIV co-infected, and 43 with prior HCV eradication) were screened for anti-HDV antibodies (anti-HD), after careful selection for negativity to any serologic or virologic marker of current or past HBV infection. One single HCV/HIV co-infected patient (0.7%) tested highly positive for anti-HD, bu
APA, Harvard, Vancouver, ISO, and other styles
2

Qadeer, Muhammad Imran, Muhammad Aslamkhan, Muhammad Shoaib Akhtar, and Fazal Ellahi. "High Seropositivity of HIV, Hepatitis and Syphilis in Prisoner Blood Donors than the General Population Volunteers from the Punjab, Pakistan –A Longitudinal 13 Years Study." International Journal of Frontier Sciences 1, no. 1 (2019): 2–11. https://doi.org/10.5281/zenodo.2545868.

Full text
Abstract:
Abstract: Background: HBV, HCV, HIV and Syphilis are leading transfusion transmitted infections. Blood donors are screened against these infectious diseases before transfusion to patients. Methods: Data of general population and volunteer prisoner blood donors is retrieved from records of January 2007 to September 2009. Data is analysed using Epi Info version 3.5.1. Blood donors were screened using ELISA method against HCV, HBV, and HIV while VDRL method is used for screening against Syphilis. Results: Prevalence of HBV, HCV, HIV, and Syphilis in general population blood donors is 3.3%, 4.7%,
APA, Harvard, Vancouver, ISO, and other styles
3

Shrestha, Lok Bahadur, Gopal K. Yadav, Saugat Pradhan, et al. "Co-infection of Hepatitis B and Hepatitis C among HIV-infected patients: A cross-sectional study from tertiary care hospital of eastern Nepal." PLOS ONE 17, no. 3 (2022): e0264791. http://dx.doi.org/10.1371/journal.pone.0264791.

Full text
Abstract:
Introduction This study was conducted with an objective to analyze prevalence and risk factors associated with co-infection of hepatitis B virus (HBV) and hepatitis C virus (HCV) in HIV-positive patients with reference to their CD4+ T cell status. Materials and methods HIV-positive patients visiting the HIV clinic for CD4+ T cells testing at B.P. Koirala Institute of Health Sciences were tested for Hepatitis B and Hepatitis C. Data regarding age, gender, mode of HIV transmission, duration of HIV diagnosis, antiretroviral therapy status, antiretroviral therapy duration, hepatitis B or C status,
APA, Harvard, Vancouver, ISO, and other styles
4

Zezerti, Idriss Mamadou, Abdelsalam Adoum Doutoum, Alhadj Markhous Nazal, et al. "Seroprevalence of HIV with Hepatitis B and C Co-Infection in Patients at the Al Nadjma Multi-purpose Center Laboratory in N'Djamena, Chad." Microbiology Research Journal International 35, no. 2 (2025): 54–62. https://doi.org/10.9734/mrji/2025/v35i21542.

Full text
Abstract:
Co-infection with hepatitis B and C is one of the major challenges in the management of HIV since access to antiretroviral drugs has improved in Africa. The aim of this study was to determine the seroprevalence HIV/Hep B and C co-infection in patients treated at the Al Nadjma multi-purpose centre in N'Djamena, Chad. This prospective study was conducted from June 2023 to May 2024 on 3,430 patients seen at the laboratory of the Al Nadjma multi-purpose Center in N'Djamena for screening for both HIV and hepatitis B and C. HIV was detected by immuno-chromatography using specific kits. The detection
APA, Harvard, Vancouver, ISO, and other styles
5

Dickson-Spillmann, Maria, Severin Haug, Ambros Uchtenhagen, Philip Bruggmann, and Michael P. Schaub. "Rates of HIV and Hepatitis Infections in Clients Entering Heroin-Assisted Treatment between 2003 and 2013 and Risk Factors for Hepatitis C Infection." European Addiction Research 22, no. 4 (2015): 181–91. http://dx.doi.org/10.1159/000441973.

Full text
Abstract:
Background/Aims: We report on the rates of hepatitis A virus (HAV), hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) in 1,313 clients entering heroin-assisted treatment (HAT) in Switzerland from 2003 to 2013. We identify predictors of HCV infection. Methods: Data were collected using questionnaires within 2 weeks of clients' first entry into HAT. Prevalence of HAV, HBV, HCV and HIV was calculated using laboratory test results collected at entry or using reports of older test results. Predictors of HCV status were identified through multiple logistic regre
APA, Harvard, Vancouver, ISO, and other styles
6

Sattarova, Gulsunai. "PREVALENCE AND GENOTYPES OF HEPATITIS B AND C VIRUS AMONG HIV-INFECTED PEOPLE." Alatoo Academic Studies 23, no. 3 (2023): 497–506. http://dx.doi.org/10.17015/aas.2023.233.50.

Full text
Abstract:
Viruses of parenteral hepatitis HBV, HCV and human immunodeficiency (HIV) are characterized by similar transmission routes and risk groups, in which the probability of acquiring two or more of these infections at once is increased. The aim of the research is to study the prevalence and determine the genotypes of hepatitis B and C virus circulating among HIV-infected people. The results of the studies show a high prevalence of HCV markers (HCV – 45% and HBV- 16%) among HIV-infected people. Co-infected patients had high viral replication of HBV (60%) and HCV (62.7%). Аlso by molecular genetic me
APA, Harvard, Vancouver, ISO, and other styles
7

Tserashkou, D. V., V. M. Mitsura, E. V. Voropaev, and O. V. Osipkina. "VIRAL COINFECTIONS IN PATIENTS WITH CHRONIC HEPATITIS B: THEIR PREVALENCE AND CLINICAL SIGNIFICANCE." Hepatology and Gastroenterology 4, no. 2 (2020): 171–76. http://dx.doi.org/10.25298/2616-5546-2020-4-2-171-176.

Full text
Abstract:
Background. Hepatitis B virus (HBV) infection remains a global public health problem. Objective – to analyze the prevalence of viral coinfections with human immunodefciency virus (HIV), hepatitis C virus (HCV), hepatitis delta virus (HDV), TT-viruses and SENV in patients with chronic hepatitis B (CHB) and to assess their influence on liver disease severity. Material and methods. The observational cross-sectional study included 287 patients with chronic hepatitis B virus (HBV) – those with monoinfection and coinfected with HIV, HCV, HDV. Routine hematological and biochemical tests were performed
APA, Harvard, Vancouver, ISO, and other styles
8

Mr., Keshava Reddy M., and Senthil Thirusangu Mr. "Viral Hepatitis - Disease Burden, Challenges and Gap Analysis with Existing Response." International Journal of Trend in Scientific Research and Development 3, no. 3 (2019): 545–47. https://doi.org/10.31142/ijtsrd22823.

Full text
Abstract:
Viral hepatitis is a global public health problem of epidemic proportions that caused 1.34 million deaths in 2015 a number comparable to deaths caused by tuberculosis and higher than those caused by HIV. Infection can be caused by the five known hepatitis viruses - A, B, C, D and E HAV, HBV, HCV, HDV and HEV . Many of these infections are preventable. Hepatitis B and C are responsible for 96 of overall hepatitis mortality. In India, the estimated burden of hepatitis is very high, necessitating focus on prevention and control measures to mitigate morbidity and mortality arising out of hepatitis
APA, Harvard, Vancouver, ISO, and other styles
9

Seyoum, Eleni, Meaza Demissie, Alemayehu Worku, Andargachew Mulu, Alemseged Abdissa, and Yemane Berhane. "HIV, hepatitis B virus, and hepatitis C virus co-infection among HIV positives in antiretroviral treatment program in selected hospitals in Addis Ababa: A retrospective cross-sectional study." PLOS ONE 17, no. 4 (2022): e0267230. http://dx.doi.org/10.1371/journal.pone.0267230.

Full text
Abstract:
Introduction HIV co-infection with hepatitis B (HIV-HBV) and hepatitis C (HIV-HCV) is known to affect treatment outcomes of antiretroviral therapy (ART); however, its magnitude is not well documented. We aimed to determine the magnitude of HIV-HBV and HIV-HCV co-infections simultaneously in people living with HIV (PLHIV) enrolled in ART care in Addis Ababa. Methods We reviewed the medical records of adults ≥15 years who were receiving ART care in three high burden hospitals in Addis Ababa. Baseline clinical and laboratory test results were extracted from medical records. Co-infection was deter
APA, Harvard, Vancouver, ISO, and other styles
10

Suman, Sonu. "Clinical, haematological, and biochemical profile of HIV patient co-infected with hepatitis B and /or C." International Journal of Research in Medical Sciences 8, no. 11 (2020): 3955. http://dx.doi.org/10.18203/2320-6012.ijrms20204885.

Full text
Abstract:
Background: Human immunodeficiency virus (HIV) positive population is at higher risk of getting infected with hepatitis B virus (HBV) or hepatitis C virus (HCV) or both. Co-infection with HBV/HCV may possibly complicate the clinical course of HIV in infected patients. Aim and objectives of the study were intended to determine clinical, haematological and biochemical profile of HIV patients co infected with hepatitis B and/or C.Methods: All consecutive patients presented with HIV infection who were coinfected with either Hepatitis B, C or both presenting to immunodeficiency or Gastroenterology
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "HIV/Hepatitis C"

1

Mohsen, Abdul Hadi. "The epidemiology of hepatitis C and HCV-HIV coinfection." Thesis, King's College London (University of London), 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.424448.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Falconer, Karolin. "HIV-1/HCV co-infection immunity and viral dynamics /." Stockholm, 2010. http://diss.kib.ki.se/2010/978-91-7409-762-7/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Yuen, King-tai, and 袁敬弟. "A study of pharmacogenomics for therapeutic and prognostic guidance towards hepatitis C virus (HCV) for patients co-infected with HIV." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2013. http://hdl.handle.net/10722/193555.

Full text
Abstract:
The cost effectiveness of using novel HCV treatment option, telaprevir and boceprevir, should depend on patients’ respond to conventional PEG-INFα and ribavirin therapy. The study of pharmacogenomics, interleukin-28B (IL-28B) polymorphisms, accompanied with the information of HCV genotypes are suggested to have the strongest predictive value of treatment outcomes and prognosis of disease in individuals infected with HCV who are undergoing conventional PEG-INFα and ribavirin therapy. It is extremely valuable in HCV/HIV co-infected patients as these groups of patients require a complex treatment
APA, Harvard, Vancouver, ISO, and other styles
4

Fialho, Renata. "Neuropsychiatric manifestations of hepatitis C treatment in HIV/HCV co-infection." Thesis, University of Sussex, 2017. http://sro.sussex.ac.uk/id/eprint/71260/.

Full text
Abstract:
Hepatitis C (HCV) infection is associated with high rates of mortality and morbidity. Interferon alpha based treatment for HCV offers a good rate of viral clearance, however the associated neuropsychiatric side effects increase the risk of treatment interruption and disease progression. The HIV/HCV coinfection is of particular interest due to association with higher rates of HCV treatment side effects and earlier treatment discontinuation when compared with HCV mono-infection. Therefore, the aim of the thesis was to further explore the effect of coinfection on mood and cognition and how HCV in
APA, Harvard, Vancouver, ISO, and other styles
5

Bertol, Bruna Cristina. "Expressão da molécula HLA-G e polimorfismos da região codificadora do gene HLA-G em pacientes infectados pelo vírus da hepatite C (HCV) apresentando ou não a coinfecção pelo vírus da imunodeficiência humana (HIV)." Universidade de São Paulo, 2016. http://www.teses.usp.br/teses/disponiveis/17/17147/tde-10012017-112046/.

Full text
Abstract:
A hepatite C, causada pelo vírus da hepatite C (HCV), afeta milhões de pessoas no mundo. A transmissão do HCV é semelhante ao HIV, justificando a alta taxa de prevalência da coinfecção. Pacientes coinfectados HCV/HIV apresentam maior taxa de progressão da fibrose hepática e da mortalidade, em comparação aos pacientes monoinfectados com HCV. Assim, o estudo de genes e/ou moléculas que controlam a resposta imune é pertinente. No presente estudo, avaliamos o papel do antígeno leucocitário humano G (HLA-G), molécula com reconhecida atividade imunomoduladora, capaz de inibir a ativação das células
APA, Harvard, Vancouver, ISO, and other styles
6

Souza, Rafael Leme Cardoso. "Avaliação tecnológica do teste molecular (NAT) para HIV, HCV e HBV na triagem de sangue no Brasil." Universidade de São Paulo, 2018. http://www.teses.usp.br/teses/disponiveis/99/99131/tde-09102018-090250/.

Full text
Abstract:
Após anos de debates, o teste de detecção de ácidos nucleicos (NAT) para HIV e HCV na triagem de sangue foi implementado de forma obrigatória no Brasil em 2013, e HBV, em 2016. Um dos motivos citados sobre o atraso em sua implementação foi o custo elevado que seria adicionado à sorologia e, até o momento, uma ampla avaliação econômica em saúde (AES) a respeito de sua eficiência no país não está disponível. Diversos artigos já demonstraram que a razão incremental de custo-utilidade (ICUR) do NAT em relação à sorologia varia de 0,21 a 8,84 milhões de dólares americanos (US$) para cada QALY ganho
APA, Harvard, Vancouver, ISO, and other styles
7

Del-Rios, Nativa Helena Alves. "Estudo epidemiológico e molecular da infecção pelo vírus da Hepatite C em indivíduos infectados pelo vírus da Imunodeficiência Humana em Goiânia-Goiás." Universidade Federal de Goiás, 2011. http://repositorio.bc.ufg.br/tede/handle/tede/7241.

Full text
Abstract:
Submitted by Erika Demachki (erikademachki@gmail.com) on 2017-04-27T18:05:38Z No. of bitstreams: 2 Dissertação - Nativa Helena Alves Del-Rios - 2011.pdf: 2685862 bytes, checksum: a88d60dfeef4b6b920f7a23cc00881a3 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5)<br>Rejected by Erika Demachki (erikademachki@gmail.com), reason: on 2017-04-27T18:05:52Z (GMT)<br>Submitted by Erika Demachki (erikademachki@gmail.com) on 2017-04-27T18:06:12Z No. of bitstreams: 2 Dissertação - Nativa Helena Alves Del-Rios - 2011.pdf: 2685862 bytes, checksum: a88d60dfeef4b6b920f7a23cc00881a3
APA, Harvard, Vancouver, ISO, and other styles
8

Gröner, Jan Benedikt. "Mitochondriale Dysfunktion bei chronischer Hepatitis B, chronischer Hepatitis C und bei HIV-Postexpositionsprophylaxe." Diss., lmu, 2011. http://nbn-resolving.de/urn:nbn:de:bvb:19-135665.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Barbosa, Alexandre Naime [UNESP]. "Avaliação das citocinas (ELISA e RT-PCR) e da fibrose hepática na coinfecção pelo HIV e vírus da hepatite C." Universidade Estadual Paulista (UNESP), 2010. http://hdl.handle.net/11449/101466.

Full text
Abstract:
Made available in DSpace on 2014-06-11T19:31:28Z (GMT). No. of bitstreams: 0 Previous issue date: 2010-06-18Bitstream added on 2014-06-13T18:42:08Z : No. of bitstreams: 1 barbosa_an_dr_botfm.pdf: 1241955 bytes, checksum: 4ebec113ac46c15142666ca4f710746d (MD5)<br>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)<br>Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)<br>Universidade Estadual Paulista (UNESP)<br>A aids e a hepatite C crônica são infecções caracterizadas por importante processo inflamatório contínuo, regulado por uma complexa interação entre citocinas
APA, Harvard, Vancouver, ISO, and other styles
10

Barbosa, Alexandre Naime. "Avaliação das citocinas (ELISA e RT-PCR) e da fibrose hepática na coinfecção pelo HIV e vírus da hepatite C /." Botucatu : [s.n.], 2010. http://hdl.handle.net/11449/101466.

Full text
Abstract:
Orientador: Domingues Alves Meira<br>Banca: Alexandrina Sartori<br>Banca: Ricardo Sobhie Diaz<br>Banca: Fernando Lopes Gonçalves Júnior<br>Resumo: A aids e a hepatite C crônica são infecções caracterizadas por importante processo inflamatório contínuo, regulado por uma complexa interação entre citocinas. A persistência da atividade inflamatória crônica está intimamente relacionada com a progressão da patogênese da aids, bem como na indução de fibrose na hepatite C. Com o objetivo de avaliar o padrão de citocinas na infecção pelo HIV e na hepatite C crônica, as citocinas IL-2, IL-4, IL-10, TNF-
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "HIV/Hepatitis C"

1

Ireland. Hepatitis C Compensation Tribunal. Annual report of the Hepatitis C Compensation Tribunal. Stationery Office, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Saskatchewan Subcommittee on HIV/AIDS. Guidelines for the management of potential exposures to Hepatitis B, Hepatitis C, HIV, and recommendations for post-exposure prophyalxis. Saskatchewan Health, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Dublin, Ireland. Minister for Justice, Equality, and Law Reform. and Trinity College (Dublin, Ireland). Dept. of Community Health and General Practice., eds. Hepatitis B, hepatitis C and HIV in Irish prisoners: Prevalence and risk. Stationery Office, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Musharraf, Husain, and Population Council (Bangladesh), eds. Prevalence of HIV, HBV, HCV and syphilis markers in pregnant women of Bangladesh. Population Council, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

San Francisco (Calif.). Dept. of Public Health. Communicable Disease Control Unit. Registry match: Chronic hepatitis B, hepatitis C infection and HIV : 2010, San Francisco, California. San Francisco Department of Public Health, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Association, American Nurses. HIV, Hepatitis-B, Hepatitis-C: Blood-borne diseases; nurses' risks, rights, and responsibilities. ANA, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Dias, Giselle. Hard time: HIV and hepatitis C prevention programming for prisoners in Canada. Canadian HIV/AIDS Legal Network = Râeseau juridique canadien VIH/Sida, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Thiemann, Lillian. Double jeopardy: The HIV/HCV co-infection handbook. Community Prescription Service, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ruiz, Juan D. Seroprevalence of HIV, hepatitis B, hepatitis C, and risk behaviors among inmates entering the California correctional system. California Dept. of Health Services, Office of Aids, HIV/AIDS Epidemiology Branch, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Tribunal of Inquiry into the Infection with HIV and Hepatitis C of Persons with Haemophilia and Related Matters. Report of the Tribunal of Inquiry into the Infection with HIV and Hepatitis C of Persons with Haemophilia and Related Matters. Stationery Office, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "HIV/Hepatitis C"

1

Salmon-Ceron, Dominique, J. E. Arends, C. Leoni, C. Solas, and G. Peytavin. "HIV/HCV Coinfection: Current Challenges." In Viral Hepatitis: Chronic Hepatitis C. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-03757-4_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ingiliz, Patrick, Maud Lemoine, and Yves Benhamou. "Chronic HCV and HIV Coinfection." In Chronic Hepatitis C Virus. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-1192-5_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sulkowski, Mark S. "Hepatitis C: Natural History." In HIV and Liver Disease. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4419-1712-6_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Poles, Michael A., and Douglas T. Dieterich. "Hepatitis C and HIV Co-Infection." In Chronic Viral Hepatitis. Humana Press, 2002. https://doi.org/10.1007/978-1-59259-104-6_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Matthews, Gail V., and Gregory J. Dore. "HIV and Hepatitis C Co-Infection." In Advanced Therapy for Hepatitis C. Wiley-Blackwell, 2011. http://dx.doi.org/10.1002/9781444346343.ch22.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Chung, Raymond, and Gyanprakash Avinash Ketwaroo. "Hepatitis C Virus Treatment in HIV." In HIV and Liver Disease. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4419-1712-6_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Carlin, Joseph, Maria Cassia Mendes-Correa, and Marina Núñez. "Hepatitis B and C." In Sexually Transmitted Infections in HIV-Infected Adults and Special Populations. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-56694-8_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Rauch, Andri, and Jürgen Kurt Rockstroh. "Hepatitis C Virus Infection and HIV." In Encyclopedia of AIDS. Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4614-9610-6_426-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Pandya, Shuchi, Misbahuddin Syed, Manuel Castro, Jamie P. Morano, and Beata Casanas. "Hepatitis C and HIV Neurological Implications." In Global Virology II - HIV and NeuroAIDS. Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-7290-6_24.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Rauch, Andri, and Jürgen Kurt Rockstroh. "Hepatitis C Virus Infection and HIV." In Encyclopedia of AIDS. Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-7101-5_426.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "HIV/Hepatitis C"

1

Paschoini, MC, LN Resende, MM Mendonça, GPM Gomide, and JU Ribeiro. "P3.181 Hepatitis c: challenging modern obstetrics." In STI and HIV World Congress Abstracts, July 9–12 2017, Rio de Janeiro, Brazil. BMJ Publishing Group Ltd, 2017. http://dx.doi.org/10.1136/sextrans-2017-053264.416.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Schmidt, Axel. "S03.4 Hepatitis C in HIV-negative MSM – a growing concern?" In Abstracts for the STI & HIV World Congress (Joint Meeting of the 23rd ISSTDR and 20th IUSTI), July 14–17, 2019, Vancouver, Canada. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/sextrans-2019-sti.27.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Brieva Herrero, MT, I. Reyes Torres, M. Sáez-Torres de Vicente, P. López López, M. Frias Casas, and A. Rivero Juárez. "4CPS-267 Lack of hepatitis C virus uptake in HIV/HCV co-infected patients." In 24th EAHP Congress, 27th–29th March 2019, Barcelona, Spain. British Medical Journal Publishing Group, 2019. http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.416.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Santos, Alaides de Abreu, Talia Hahn Augusto, Geovane Barbosa da Silva, et al. "Vírus da hepatite C em pacientes hemodialisados: uma breve revisão." In XIII Congresso da Sociedade Brasileira de DST - IX Congresso Brasileiro de AIDS - IV Congresso Latino Americano de IST/HIV/AIDS. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/dst-2177-8264-202133p250.

Full text
Abstract:
Introdução: A hepatite C é um problema de saúde pública, com maior prevalência em pacientes com doença renal crônica. Objetivo: Conhecer a relação do vírus da hepatite C em pacientes hemodialisados. Métodos: Foi realizada uma revisão bibliográfica, com abordagem qualitativa. A busca artigos ocorreu em março de 2019. Foram selecionados artigos no idioma de português e inglês, extraídos de sites de coleção como LILACS, SciELO, PubMed, EBSCO e Ministério da Saúde, no período de 2009-19 e utilizados os seguintes descritores em português: HCV, hepatite C, hemodiálise, doença renal, diálise. E, em i
APA, Harvard, Vancouver, ISO, and other styles
5

Mckee, Geoff, Nuria Chapinal, Zahid Butt, et al. "P388 Evolution of hepatitis C care cascades among HIV and hepatitis B co-infected patients in british columbia, canada." In Abstracts for the STI & HIV World Congress (Joint Meeting of the 23rd ISSTDR and 20th IUSTI), July 14–17, 2019, Vancouver, Canada. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/sextrans-2019-sti.483.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Rey, MB Contreras, J. Estaire Gutiérrez, R. Sánchez del Moral, MM Romero Alonso, MA Bolivar Raya, and C. Bocanegra Martín. "5PSQ-046 Direct-acting antivirals for hepatitis c virus in hiv co-infected patients." In Abstract Book, 23rd EAHP Congress, 21st–23rd March 2018, Gothenburg, Sweden. British Medical Journal Publishing Group, 2018. http://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.400.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Prasad, Yash, Khine Phyu, Lee Parker, Mark Aldersley, and Emma Page. "P63 ‘Get tested LeEDs’: testing for hepatitis B, hepatitis C and HIV in an Urban emergency department via notional consent." In BASL Abstracts, 21–23 September, 2020. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2020. http://dx.doi.org/10.1136/gutjnl-2020-basl.73.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ronchi, Bruna Ribas, Gabriela Marçal Rios, Rosalie Kupka Knoll, and Carolina Cardoso. "P3.29 Prevalence of hiv, sifilis, hepatitis b and hepatitis c in the inmates of the penitentiary complex of vale do itajaÍ-sc." In STI and HIV World Congress Abstracts, July 9–12 2017, Rio de Janeiro, Brazil. BMJ Publishing Group Ltd, 2017. http://dx.doi.org/10.1136/sextrans-2017-053264.266.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kerschberger, B., N. Ntshalintshali, M. Mafomisa, et al. "High burden of sexually transmitted infections and poor diagnostic performance of syndromic approaches within a decentralised HIV care setting in Eswatini." In MSF Scientific Day International 2023. MSF-USA, 2023. http://dx.doi.org/10.57740/4e0e-e138.

Full text
Abstract:
INTRODUCTION Sexually transmitted infections (STI’s) are a public health threat. Syndromic approaches based on clinical symptoms have been suggested as having poor diagnostic performance, particularly in the type of settings where MSF is operational. We assessed the burden of STI’s and the diagnostic performance of a syndromic approach within an MSF-supported HIV/STI project in Eswatini. METHODS We conducted a cross-sectional study, enrolling adults accessing routine HIV testing and antiretroviral care services in six clinics in Shiselweni, from July 2022 to January 2023. HIV testing counselor
APA, Harvard, Vancouver, ISO, and other styles
10

Sow, P. "P432 The prevalence of co-infection with HIV, Hepatitis C and TB among patients infected by HIV/AIDS in Senegal." In Abstracts for the STI & HIV World Congress, July 14–17 2021. BMJ Publishing Group Ltd, 2021. http://dx.doi.org/10.1136/sextrans-2021-sti.452.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "HIV/Hepatitis C"

1

Goller, Jane, Stephanie Munari, Cassandra Caddy, et al. General Practice engagement: STI, HIV and viral hepatitis care. The Sax Institute, 2023. http://dx.doi.org/10.57022/lnur4773.

Full text
Abstract:
Early detection and treatment of sexually transmitted infections, HIV, and hepatitis B and C are vital to minimise the harm they cause. This Evidence Check aimed to identify effective initiatives that engage and support GPs and the GP clinic workforce in NSW to increase testing for these conditions. It also aimed to identify effective modifications to practice management software to increase GP engagement in screening and care for these conditions. Sixty-two articles were found in total. The most effective initiatives used multiple interventions, particularly provider education and quality imp
APA, Harvard, Vancouver, ISO, and other styles
2

Buresh, Christopher. The Opioid Epidemic in Iowa and the Connection to Hepatitis C and HIV Outbreaks. University of Iowa Public Policy Center, 2019. http://dx.doi.org/10.17077/rep.001111.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Goldstein, Neal. Epidemiology Blog of Neal D. Goldstein, PhD, MBI. Neal D. Goldstein, 2023. http://dx.doi.org/10.17918/goldsteinepi.

Full text
Abstract:
Musings on topics related to epidemiology, epidemiological methods, public and clinical health. Written by Neal D. Goldstein, PhD, MBI. Dr. Goldstein is an Associate Professor of Epidemiology at the Drexel University Dornsife School of Public Health. With a background in biomedical informatics, he focuses on computational approaches in complex data settings, especially electronic health records and disease surveillance, to understand infectious disease transmission. This has been demonstrated through his work with blood borne pathogens (HIV and hepatitis C), COVID-19, vaccine preventable disea
APA, Harvard, Vancouver, ISO, and other styles
4

Tsai, Tsung-Yu, Guan-Jhou Chen, Hsin-Yun Sun, and Chien-Ching Hung. Diagnostic Performance of Hepatitis C Virus Core Antigen for Acute HCV Infection among People with HIV: A Systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2025. https://doi.org/10.37766/inplasy2025.3.0106.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Saraswati, Lopamudra, Mary Sebastian, Avina Sarna, et al. Prevalence of HIV, hepatitis B and C, and co-infection in a cohort of male injection drug users in Delhi. Population Council, 2013. http://dx.doi.org/10.31899/hiv10.1001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Mark, Tami L., William N. Dowd, and Carol L. Council. Tracking the Quality of Addiction Treatment Over Time and Across States: Using the Federal Government’s “Signs” of Higher Quality. RTI Press, 2020. http://dx.doi.org/10.3768/rtipress.2020.rr.0040.2007.

Full text
Abstract:
The objective of this study was to track trends in the signs of higher-quality addiction treatment as defined by the National Institute on Drug Abuse, the National Institute on Alcohol Abuse and Addiction, and the Substance Abuse and Mental Health Services Administration. We analyzed the National Survey of Substance Abuse Treatment Services from 2007 through 2017 to determine the percent of facilities having the characteristics of higher quality. We analyzed the percent by state and over time. • We found improvements between 2007 and 2017 on most measures, but performance on several measures r
APA, Harvard, Vancouver, ISO, and other styles
7

Tangkijvanith, Pisit. Prevalence and Clinical Significance of Hepatitis B Viral Genotypes and Mutations. Faculty of Medicine, Chulalongkorn University, 2006. https://doi.org/10.58837/chula.res.2006.24.

Full text
Abstract:
Hepatitis B virus (HBV) infection is a major public health problem, with more than 400 million HBV carriers estimated worldwide. Chronic HBV infection is associated with a diverse clinical spectrum of liver damage ranging from asymptomatic carrier status, chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC). There have been increasing lines of evidence to indicate influences of HBV genotypes and mutations on the outcome of liver disease, particularly the development of HCC. The project is aimed to study the prevalence and clinical significance of genotypes and mutations in Precore/
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!